Drug Safety Update
November 2020: Ferric carboxymaltose (Ferinject▼): risk of symptomatic hypophosphataemia leading to osteomalacia and fractures
December 2014: Intravenous iron and serious hypersensitivity reactions: strengthened recommendations
Local Prescribing Guidance
See local Trust guidance.
MTW: please see Q-pulse for local prescribing proforma
Please note that Monofer should be considered as a first list treatment option with regard to IV iron. If Monofer is not considered suitable, then discuss the case with the consultant in charge of the patient.
